COR vs LIVN: fair value comparison
Cencora, Inc. and LivaNova PLC · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our discount ranking. LIVN carries the stronger quality grade.
| COR | LIVN | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $322.03 | $82.46 |
| 12-month range | $264.69–$372.65 | $50.61–$82.48 |
| Sector rank | #73 of 113 Healthcare | #76 of 113 Healthcare |
| Quality grade | F | D |
| Momentum grade | C | — |
| Leverage | High | Low |
| Margin trend | Stable | — |
| Revenue growth | Strong | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: COR fair value analysis · LIVN fair value analysis